ArticleBMC oral health2025
A recurrent OKC infected with actinomyces.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe postoperative recurrence of mandibular odontogenic keratocyst (OKC) accompanied by secondary actinomycotic osteomyelitis is extremely rare and presents significant challenges in clinical diagnosis and treatment. This case study combines imaging, pathological data, and relevant literature to offer guidance for clinical management. PATIENT INFORMATION: A 21-years-old female patient underwent surgical treatment for a polycystic OKC of the mandible 4 years ago. She was hospitalized again due to sharp subgingival sensation under the labial gums in the mandibular anterior tooth area. Pathological examination revealed OKC and chronic actinomycetic osteomyelitis. Mandibular mass resection and curettage of chronic osteomyelitis were performed. Clindamycin was used continuously for 4 weeks after operation, and the prognosis was good.
conclusionOKC frequently recurs after surgery and can damage the oral mucosal barrier, potentially leading to actinomycotic osteomyelitis. Pathology is crucial for accurate diagnosis. Surgical resection of secondary OKC, and postoperative administration of standard antibiotics are effective treatment methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.